
Lactic Acidosis
Types of Lactic acidosis | Notes |
Type A | • Hypoperfusion / hypoxia Examples • Shock • Cardiac failure • Severe anemia • Carbon monoxide toxicity • Cyanide toxicity |
Type B | • metabolic causes with normal oxygenation Examples • Malignancy • Renal failure • Hepatic failure • Drugs: metformin, ethanol, ethylene glycol, methanol • Diabetes mellitus • Seizures • Severe malaria / cholera |


Renin-Angiotensin-Aldosterone System (RAAS)

- Initiated: In response to low BP.
Mediator | Effect |
Angiotensin II | • ↑ BP (direct vasoconstriction) • Stimulates aldosterone release (from adrenal cortex) |
Aldosterone | ↑ Na+ reabsorption |
Clinical Relevance:
- Overactive RAAS → Hypertension
- Treatment of HTN:
- ACE inhibitors
- Direct renin blockers:
- Aliskiren (blocks renin directly).
Calculation of GFR
ㅤ | Equation |
Best | CKD-EPI equation > MDRD equation (Modification of Diet and Renal Disease / Chronic Kidney Disease Epidemiology Problems Initiative) |
Bedside | Cockcroft and Gault equation |
Cockcroft and Gault Equation
- Creatinine clearance = (140 - Age) x Body weight x 0.8 (if female)
72 x S. creatinine
Problems with Cockcroft and Gault Equation
Clearance | ㅤ | ㅤ |
Creatinine | GFR + Tubular secretion | Overestimates GFR. |
Urea | GFR - Tubular reabsorption | Underestimates GFR. |
Inulin | = GFR ≈ 100-120 mL/min | Gold standard test |
Advantages of CKD-EPI and MDRD Equations
- Calculate GFR directly.
- Use standardized methods for creatinine estimation.
- Based on isotope dilution mass spectroscopy.
- Have replaced weight with race in calculations.
Erythropoietin Source
ㅤ | Kidney | Liver |
Secretion | 85-90%. | 10-15%. |
Cellular Source | Peritubular capillary cells | Perivenous hepatocytes |
- Note:
- Renin → JG cells
- Erythropoietin → Peritubular capillary cells
Clearance
- Definition: Volume of plasma completely cleared of a substance per unit time.
- Clearance (C) = (U x V)
P
ㅤ | ㅤ | ㅤ |
U | Urinary concentration of substance | mg/mL |
V | Urine flow rate (volume/minute) | mL/min |
P | Plasma concentration of substance | ㅤ |
(U x V) | Amount of substance excreted in urine per minute | mg/min |
Urinary Amount =
- Filtration + Secretion - Reabsorption.
Problems with Creatinine
- More muscle mass = more creatinine.
- Not dependent on obesity.
- Time gap between AKI and Creatinine rise
- 24 to 48 hours
- Overestimates GFR.
- Physiologically, rise after 40 years
- False ↑↑ when using drugs like trimethoprim and cimetidine
- Compete with Creatinine for tubular secretion
Other markers
New Markers | Early Markers for AKI |
• Cystatin C ↳ For Patients with extremes of muscle mass ↳ Non-specifically elevated in inflammation | • Kidney Injury Molecule 1 (KIM-D) • Neutrophil Gelatinase Associated Lipocalin (NGAL) • Liver Fatty Acid Binding Protein (LFABP) • TIMP2, IGFBP7. |
Graphs Illustrating Nephron Handling





Clearance Sequence (Highest → Lowest):
- PAH > Creatinine > Inulin > Urea > Sodium/Potassium > Glucose.
- PCI → UCN → HGA
Inulin Clearance
- Filtration Rate = GFR = 125 ml/min
Plasma Concentration
Substances
Substance secreted [Clearance > GFR] | Clearance | ㅤ |
PAH | • 625 ml/min d/t high secretion ↳ lower concentrations = RPF ↳ higher concentration = Falsely Low | = Renal Plasma Flow (RPF) |
Creatinine | • Secreted | • < PAH clearance • > Inulin clearance |
Neither secreted Nor absorbed | ㅤ | ㅤ |
Inulin | • Freely filterable ↳ Urinary Amount = Filtration Rate • 125 ml/min • Constant regardless of plasma concentration | = GFR |
Substance reabsorbed [Clearance < GFR] | ㅤ | ㅤ |
• Urea • Sodium and Potassium • Glucose / Amino Acids | Glucose / Amino Acids • Completely reabsorbed • Clearance: Zero (Non diabetic) | Diabetic: High plasma levels → transporter saturation → substance in urine → positive clearance |
Secretion of Para-Amino Hippuric Acid (PAH)

- 1. Early part of excretion:
- Curve is more steep.
- Involves both Filtration + secretion.
- 2. Late part of excretion:
- Curve becomes less steep.
- Only Filtration.
Saturation of SGLT-2 (Glucose Reabsorption)

Maximum transport capacity (TmG) of SGLT-2
- At 200 mg/dL of plasma glucose
- 375 mg/min of glucose is reabsorbed.
- Saturation occurs.
- Excess glucose is excreted (glycosuria).
Splay
- Occurs due to:
- Diverse/heterogeneous nephrons.
- Each nephron has different TmG.
- Causes early appearance of glucose in urine before actual TmG.

Ans
3
Clearane = uv/p = 10
less than 125 mg/ml
Graph: TF/P Ratio vs Proximal Tubule Length

- TF/P = Tubular Fluid / Plasma concentration ratio
Key Concepts
TF/P | Reabsorption | ㅤ |
> 1 | < water | Creatinine, Cl⁻ |
= 1 | = water | Urea, Na⁺, Osm |
< 1 | > water | HCO₃⁻, Amino Acids, Glucose |
Water Reabsorption and ADH Action

Segment | % of filtered water reabsorbed | ㅤ |
Obligatory Water Reabsorption (ADH Independent) | ㅤ | ㅤ |
PCT | 65-70% (Maximum with or without ADH) | ㅤ |
Descending Thin Segment | 15% | ㅤ |
Water Impermeable Segment | ㅤ | ㅤ |
Thick Ascending Limb (TAL) | 0 % | ㅤ |
Facultative Water Reabsorption (ADH Dependent) | WITH ADH | WITHOUT ADH |
CD >> DCT | ~2% | ~15% |
Mechanism of ADH Action (on collecting duct cells):

- Most potent stimulus for ADH secretion.
- Plasma osmolality > 280 mOsm/L
- MOA
- Acts on collecting duct cells → bind V2 receptors.
- Activate V2 receptor (basolateral) → ↑ cAMP
- ↑↑ cAMP → AQP2-containing vesicles fuse with luminal membrane → water enters cell from tubular lumen
- Water exits to blood via AQP3/AQP4 (basolateral, constitutive, not ADH-regulated).
Diabetes Insipidus


ㅤ | Central/Neurogenic DI | Nephrogenic DI |
ADH secretion | Low plasma ADH | ㅤ |
ADH action | ㅤ | ↓↓ [d/t mutation of V2 receptor gen] |
ADH injection | Reduces urine volume. | • Does not reduce urine volume. • Urine osmolality remains low |
Countercurrent System

Osmolality | ㅤ |
Serum | 285–290 mOsm/kg |
Urine | 800–900 mOsm (more concentrated) |
Kidney mechanism
- Countercurrent multiplication → Loop of Henle
- Countercurrent exchange → Vasa recta
Requirements (4):
- Two parallel tubes
- Opposite flow
- Close proximity
- Selective permeability
Other countercurrent systems (MCQ-relevant):
- True countercurrent:
- Kidney (Loop of Henle)
- Testes (Pampiniform plexus)
- Intestinal villi
- Skin (heat exchange)
- Not true countercurrent:
- Lungs → Crosscurrent
- Liver
Medullary Hyperosmolarity

ㅤ | Function | Section |
Creation | Countercurrent Multiplier | Loop of Henle |
Maintenance | Countercurrent Exchanger | Vasa recta |
- Medullary Hyperosmolarity
- Enables ADH-dependent water reabsorption in collecting ducts
- Note
- highest osmolality with
- Inner medulla
- Longer LOH (up to 1200 mOsm).
ㅤ | Long LOH | Short LOH |
Includes | Juxtamedullary nephron, Cortical nephron. | ㅤ |
% | 15% | 85% |
Role | Responsible for concentration & dilution of urine | ㅤ |
ADH (Vasopressin)
- Receptor: V2 receptors (Basolateral membrane of CD).
- Mechanism: ↑ cAMP → ↑ Expression of Aquaporin 2 (Luminal membrane).
- Result: Reabsorption of salt-free water utilizing medullary hyperosmolarity.
1. Medullary Hypertonicity
Substance | Contribution | Source / Mechanism |
Na + Cl | 60% ↳ Na = 30% ↳ Cl = 30% | • Thick Ascending Limb of LOH. |
Urea | 40% | • Single most important substance • Collecting Duct (CD) via UTA1 & UTA2. • Contribution ↑ with high protein diet |
2. Loop of Henle: Countercurrent Multiplier
- Input: Isotonic fluid (300 mOsm/L) from PCT
- Function: Concentrates and dilutes urine
ㅤ | Thin Descending Limb | Thick Ascending Limb |
aka | Concentrating Segment | Diluting Segment |
Role | Generation of medullary hypertonicity | Active solute reabsorption Single effect: ↳ Na+ transport without water |
Permeability | • Permeable to Water • Impermeable to Na+. | • Permeable to Solutes • Impermeable to Water |
Mechanism | Water is reabsorbed via AQP1 ↳ Tubular fluid concentrates | Na+, K+, Cl- cotransporter ↳ ⛔ by Loop diuretics |
Osmolality | 300 → 600 → 900 → 1200 mOsm/L | 1200 → 900 → 600 → 100 mOsm/L |
- Note: Outer medullary osmolality remains 290 mOsm.
3. Vasa Recta: Countercurrent Exchanger


- Structure: Blood vessels running alongside LOH.
- Mechanism: Acts as a countercurrent exchange system.
- Urea Role:
- Maintain interstitial osmolality created by LOH.
- Reabsorbed from inner medullary collecting duct.
- Recycled via Vasa Recta.
4. Collecting Duct (CD)
- Water Reabsorption:
- H2O exits to medulla via AQP2-4.
- Regulated by ADH.
- Urea Reabsorption:
- Occurs in Inner Medulla.
- Moves to interstitium via UT-A1.
5. Urea recycling:

- Goal: Keeps Urea within medullary interstitium to maintain high osmolality gradient.
Step | Location | Transporter |
Entry | Descending limb of Vasa Recta | UT-B |
Exit | Ascending limb of Vasa Recta | UT-B |
Re-entry | Thin Descending Limb of LOH | UT-A2 |
Filtration Fraction
- Formula: FF = GFR / RPF = 0.1 to 0.2
- Renal Plasma Flow (RPF): 700 ml/min
- (Clearance of PAH)
- Renal Blood Flow (RBF): 1200 ml/min.
- Importance of FF
- After filtration, peritubular capillaries has:
- ↑ Protein concentration
- ↑ Oncotic pressure
- Favors reabsorption of water + solutes from tubules
- Helps maintain medullary osmotic gradient
- Fractional Excretion of Sodium (FeNa)
- (Clearance of Sodium / GFR) OR
- (Urine Sodium x Plasma Creatinine) / (Plasma Sodium x Urine Creatinine)
Ion Reabsorption
Ion | Location | Lumen to Cell | Cell to Peritubular Capillary |
Ca2+ | Ascending LOH | Na+K+2Cl- cotransporter | K+ recycling ↳ creates positive charge ↳ K+ repels Ca2+/Mg2+ ↳ Reabsorbed |
Ca2+ | DCT [9% filtered load of calcium] | Transient receptor potential vanilloid channel (TRPV 5) ↑↑ by PTH and Vitamin D | Na+-Ca2+ exchanger |
Cl- | Ascending LOH (LOH cells) | Na+K+2Cl- cotransporter | Chloride channel (Barttin) |
Na+ | DCT [5% filtered load] | Na+-Cl- cotransporter | Na+-K+ pump |
Note
- Hormone Responsible for Calcium absorption
- PTH and Vit D → Upregulate TRPV 5 in DCT
- Ion responsible for Calcium and Magnesium (Divalent ions)
- K+ → Ascending LOH




↳ Gitelman's syndrome
Bartter Syndrome

- AR inheritance
- Defect:
- Na⁺-K⁺-2Cl⁻ cotransporter (TAL of LoH) OR
- Barttin channel
- Consequences:
- Polyuria, salt wasting
- ↑Ca²⁺ excretion → Nephrocalcinosis
- Activation of RAAS →↑ Na+, H2O reabsorption → Normal/low BP
- Hypokalemic hypochloremic metabolic alkalosis
Reabsorption in PCT

Hormones with action on PCT | Function | Notes |
PTH | ↑ PO4 excretion | ㅤ |
Angiotensin | ↑ Na/ H2O/ Bicarbonate | Contraction alkalosis |
Acetazolamide | ⛔ reabsorption of HCO3 | Acidazolamide → RTA 2 |
SGLT2⛔ | ⛔ reabsorption of glucose | Glucosuria |
Proportional Reabsorption of Filtered Substances
Substance | Lumen to PCT Cell | Percentage Reabsorbed | Notes |
NaCl | Na⁺-H⁺ exchanger | 67% (2/3rd) | ㅤ |
H₂O | ㅤ | 67% (2/3rd) | ISOTONIC ABSORPTION • Equal Na⁺ and H₂O are reabsorbed. • Results in isotonic fluid PCT |
K⁺ | ㅤ | 67% (2/3rd) | ㅤ |
Urea | ㅤ | 67% (2/3rd) | ㅤ |
Ca²⁺ | ㅤ | 70% | ㅤ |
Phosphate | Na⁺-PO₄²⁻ cotransporter | 80% | ㅤ |
Bicarbonate | ㅤ | 80% | ㅤ |
Glucose | SGLT 2 | 100% | PCT is the only segment absorbing glucose |
Amino acids | Na⁺-amino acid cotransporter | 100% | ㅤ |
Chloride (Cl⁻) Reabsorption:
- Cl⁻ ↑↑ in concentration in lumen
- Due to preferential Na⁺ absorption in the early PCT.
- Cl⁻ is reabsorbed in the later parts of the PCT.

Class | MOA & Site | Enzyme | Effects |
Carbonic Anhydrase Inhibitors / | PCT | Block carbonic anhydrase (Fanconi) ↳ Fanil acid ozhich ↳ Hypokalemic Metabolic acidosis | Acidazolomide ↳ Sulfa drug ↳ Hypokalemia ↳ Acidosis (HCO₃⁻ loss) |
Loop Diuretics | TAL | Block Na+-K+-2Cl- pump/ Chloride channel (Barttin) (Bartter syndrome) | Loop diuretics → all low • Hyponatremia • Hypokalemia • Gout • Hypochloremia • Hypocalcemia • Indirect vasodilators ↳ (↑ prostaglandins). Hypokalemic hypochloremic metabolic alkalosis + ↑Ca²⁺ excretion (Nephrocalcinosis) |
Thiazides | DCT | Block Na-Cl cotransporter (Gitelman syndrome) Gitel man → Gita maggy (magnesium) undakk | • Hyponatremia • Hypokalemia • Gout • Postural Hypotension • Hyperglycemia • Hypercalcemia • Hypomagnesemia • Direct vasodilators ↳ open K+ channels Hypokalemic metabolic alkalosis + Hypomagnesemia |
Osmotic Diuretics | PCT & loop | Solute-free water loss | ㅤ |
Potassium-Sparing Diuretics | ㅤ | ㅤ | ㅤ |
Spironolactone/ Eplerenone: | CD | Block aldosterone. | • Hyponatremia • Hyperkalemia • Gynecomastia |
Amiloride | CD | Blocks ENaC (Liddle syndrome) ↳ SCNN1B/G genes ↳ AD inheritance ↳ Little Hypertensive | • Hyponatremia • Hyperkalemia • Alkalosis + HTN |
Mnemonic: FABulous Glittering Liquid
- Gordon
- Opp of Gitelman
- Psudo-hypoaldosteronism
- Opp to Liddle
Cystometrogram


Segment | Bladder Vol. | Bladder Press | Reason |
1a: | till 100 mL | Small pressure rise | ㅤ |
At | 150 mL | ㅤ | • 1st urge to void |
1b | 100 - 400 mL | Pressure remains constant | • Laplace's Law (Pressure ∝ Wall Tension / Radius) • Plasticity property of smooth muscle |
2: | > 400 mL | rises sharply | • Triggers micturition reflex |
Aquaporins
Applied Aspect
Vaptans (conivaptan):
- Vasopressin receptor blockers
- ↑↑ pure water excretion in urine.
Vasopressin escape
- In SIADH
- Kidney escapes ADH effect by downregulation of Aqp-2.
Factors Affecting ADH Secretion
- ↑↑ ADH Secretion
- Painful stimuli
- Nausea and vomiting
- ↑ osmotic pressure
- ↓ ECF volume
- ↓↓ ADH Secretion
- Alcohol (inhibits ADH)
- ↓ osmotic pressure
- ↑ ECF volume
Actions Mediated by Vasopressin Receptors
Receptor | Site | Drug | Use |
V1 | Blood vessel ↳ Vasoconstriction | Terlipressin | Esophageal varices |
V2 | Collecting duct Vascular endothelium ↳ Release of vWF | Desmopressin (ROA: Intranasal) | Von willebrand disease |
V3 | Anterior pituitary ↳ ACTH release | - | ㅤ |
Free Water Clearance

Seen In | Clearance Type | Urine Concentration | ADH Level |
SIADH | Negative | ↑↑↑↑ | High |
Diabetes insipidus | Positive | ↓↓↓↓ | Low/absent |
Natriuretic Peptides
- Messenger: cGMP.
- Types of Natriuretic Peptides
Type | Site | Analogue |
A type (ANP) | Atrium | ㅤ |
B type (BNP) | Ventricles | Nesiritide |
C type (CNP) | Vascular endothelium | ㅤ |
- Site of Action
- Terminal DCT and CD.
- Actions
Action | Key Point | Mechanism / Effect |
1 | Natriuresis | Afferent arteriole dilation → ↑ GFR → ↑ Na⁺ excretion |
2 | Physiological Antagonism With RAAS | ↑ Na⁺ → ANP activated; ↓ Na⁺ → RAAS activated |
Regulation | ㅤ | ㅤ |
↑ ANP | Fluid overload | Stretch of atria → ↑ ANP release |
↓ ANP | Hypovolemia | Reduced atrial stretch → ↓ ANP release |
Aldosterone escape:
- Kidneys escape effect of aldosterone in hyperaldosteronism.
- ↑↑ aldosterone → ↑↑ Na+ & H2O reabsorption → ↑↑ BP
- but no edema
- d/t ANP: Pressure diuresis
Aldosterone

- t½: 20 mins.
Site 1: Primarily in Principal Cell (CD)
- Collecting duct
- Aldosterone acts on Mineralocorticoid Receptor (MR)
- MR (Inactive) → Aldosterone binding → Active MR → ↑↑ activity of
- Overall: Na⁺ reabsorption & K⁺ secretion.
Specific Channels | Function |
ENaC | ↑ Na⁺ reabsorption |
ROMK (Renal Outer Medullary K⁺ channel) | ↑ K⁺ secretion |
Na⁺-K⁺ ATPase (basolateral membrane): | Pumps 3 Na⁺ out and 2 K⁺ into the cell → maintaining gradient. |
Site 2: Type A Intercalated Cell (DCT)
- ↑ H⁺ secretion via H⁺-ATPase
- Overall: H⁺ secretion and HCO₃⁻ reabsorption ⇒ Metabolic alkalosis

MR sites:
- Kidneys, colon, hippocampus, salivary glands, sweat glands.
Factors Regulating Aldosterone Synthesis
- Hyperkalemia → Stimulates aldosterone release.
- ACTH → Increases aldosterone transiently.
Intercalated cells
Dominant Cell | Site | Process | Result |
Type A intercalated | • DCT | A Attract B H⁺ secreted, HCO₃⁻ reabsorbed | In Acidosis → ↑ plasma HCO₃⁻ |
Type B intercalated | • Late DCT • Cortical collecting duct | B Repel B H⁺ reabsorbed, HCO₃⁻ secreted | In Alkalosis → ↓ plasma HCO₃⁻ (excreted) |
Bicarbonate Excretion

- Proximal Tubule (85%)
- via Na⁺/H⁺ exchanger (NHE3)
- Type B intercalated cells
- Actively secrete HCO₃⁻ via pendrin
- Pendrin = major transporter for HCO₃⁻ excretion.
